• 1
    Altschup SF, Gish W, Pennsylvania T, Park U: Basic Local Alignment Search Tool Department of Computer Science. 1990:40310.
  • 2
    Carrier CA, Elliott TB, Ledney GD: Resident bacteria in a mixed population of rhesus macaque (Macaca mulatta) monkeys: a prevalence study. J Med Primatol 2009; 38:397403.
  • 3
    Chen CC, Teng LJ, Chang TC: Identification of Clinically Relevant Viridans Group Streptococci by Sequence Analysis of the 16S-23S Ribosomal DNA Spacer Region. J Clin Microbiol 2004; 42:2651.
  • 4
    Kanamori S, Kusano N, Shinzato T, Saito A: The role of the capsule of the Streptococcus milleri group in its pathogenicity. J Infect Chemother 2004; 10:1059.
  • 5
    Kumar S, Fox B, Owston M, Hubbard GB, Dick EJ: Pathology of spontaneous air sacculitis in 37 baboons and seven chimpanzees and a brief review of the literature. J Med Primatol 2012; 41:26677.
  • 6
    Laupland KB, Ross T, Church DL, Gregson DB: Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clin Microbiol Infect 2006; 12:22430.
  • 7
    Shinzato T, Saito A: A mechanism of pathogenicity of “Streptococcus milleri group” in pulmonary infection: synergy with an anaerobe. J Med Microbiol 1994; 40:11823.
  • 8
    Siegman-Igra Y, Azmon Y, Schwartz D: Milleri group streptococcus–a stepchild in the viridans family. Eur J Clin Microbiol Infect Dis 2012; 31:24539.
  • 9
    Unsworth PF: Hyaluronidase production in Streptococcus milleri in relation to infection. J Clin Pathol 1989; 42:50610.
  • 10
    Willcox MD: Potential pathogenic properties of members of the “Streptococcus milleri” group in relation to the production of endocarditis and abscesses. J Med Microbiol 1995; 43:40510.
  • 11
    Zimmermann N, Pirovino M, Zingg R, Clauss M, Kaup FJ, Heistermann M, Hatt JM, Steinmetz HW: Upper respiratory tract disease in captive orangutans (Pongo sp.): prevalence in 20 European zoos and predisposing factors. J Med Primatol 2011; 40:36575.